23 Feb 2024 • In a recent advisory, the FDA is cautioning consumers, patients, and caregivers against the purchase and use of smartwatches or smart rings claiming to measure blood glucose levels.

Emphasizing the lack of FDA review on the safety and effectiveness of these devices, the agency warns of potential inaccuracies in blood glucose measurements, posing significant risks for those dependent on precise readings for medical care.

Healthcare professionals are urged to communicate these risks to their patients and assist them in selecting appropriate and authorized blood glucose measuring devices.

Source: FDA | Read full story